Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

Detalles Bibliográficos
Autores principales: Tsikas, Dimitrios, Beckmann, Bibiana, Araujo, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127108/
https://www.ncbi.nlm.nih.gov/pubmed/27801791
http://dx.doi.org/10.3390/toxins8110311
_version_ 1782470211858857984
author Tsikas, Dimitrios
Beckmann, Bibiana
Araujo, Pedro
author_facet Tsikas, Dimitrios
Beckmann, Bibiana
Araujo, Pedro
author_sort Tsikas, Dimitrios
collection PubMed
description
format Online
Article
Text
id pubmed-5127108
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-51271082016-12-02 Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149 Tsikas, Dimitrios Beckmann, Bibiana Araujo, Pedro Toxins (Basel) Comment MDPI 2016-10-27 /pmc/articles/PMC5127108/ /pubmed/27801791 http://dx.doi.org/10.3390/toxins8110311 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Tsikas, Dimitrios
Beckmann, Bibiana
Araujo, Pedro
Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_full Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_fullStr Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_full_unstemmed Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_short Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_sort comments on boelaert et al. determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: uplc–ms/ms versus elisa. toxins 2016, 8, 149
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127108/
https://www.ncbi.nlm.nih.gov/pubmed/27801791
http://dx.doi.org/10.3390/toxins8110311
work_keys_str_mv AT tsikasdimitrios commentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149
AT beckmannbibiana commentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149
AT araujopedro commentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149

Ejemplares similares